Dexcom (DXCM) Acquisitions (2021 - 2022)
Dexcom (DXCM) posted quarterly Acquisitions of $700000.0 for Q3 2022, down 97.78% year-over-year from $31.6 million in Q3 2021, and down 78.12% quarter-over-quarter from $3.2 million in Q1 2022.
Dexcom (DXCM) Acquisitions (2021 - 2022) Analysis & Trends
Dexcom (DXCM) has reported Acquisitions for 2 consecutive years, with $700000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Acquisitions fell 97.78% year-over-year to $700000.0; the TTM figure through Jun 2023 stood at $700000.0 (down 97.9% YoY), while the FY2022 annual figure was $3.9 million, down 87.09% from the prior year.
- Acquisitions retreated to $700000.0 in Q3 2022 per DXCM's latest filing, from $3.2 million in the prior quarter.
- Across five years, Acquisitions topped out at $31.6 million in Q3 2021 and bottomed at -$1.4 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 437.00 Mn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 406.00 Mn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | -4.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | -3.49 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 16.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 700,000.00 |
| Mar 31, 2022 | 3.20 Mn |
| Dec 31, 2021 | -1.40 Mn |
| Sep 30, 2021 | 31.60 Mn |